GREENVILLE: Jadex Inc. announced the retirement of current Chief Executive Officer Chuck Villa and the appointment of Dr. David Moody to serve as Chief Executive Officer, effective March 22, 2021.

Most recently, Dr. Moody served as Executive Vice President and Division President, Chemicals at Milliken & Company. Mr. Villa will remain a senior advisor to, and investor in, Jadex.

Dr. Moody brings significant specialty manufacturing and materials science experience to Jadex from his 33-year tenure at Milliken & Company. As President of the Chemical Division, he oversaw product research and development, sales, marketing and manufacturing of multiple business segments.

Prior to leading the Chemical Division, he held a number of management roles at Milliken, including President of Milliken’s Floor Covering Division, President of Milliken’s Apparel Division, and President of Milliken Research Corporation.

“Jadex has attracted an impressive customer base through its unique manufacturing and research and development capabilities, and I am excited to lead the business into its next phase of growth,” Dr. Moody said.

“David is a seasoned, respected executive who aligns well with our culture of collaboration, innovation and thought leadership. His wealth of management and industry expertise will be invaluable to the ongoing growth of our Alltrista, LifeMade, Shakespeare and ARTAZN brands,” said Michael Modak, an Operating Partner for One Rock Capital Partners and a member of the Jadex Board of Directors.

“We would like to thank Chuck for his long-time leadership and many contributions to the company.”

“I am proud of our achievements at Jadex and am confident that the company is in good hands under David’s leadership. I look forward to continuing to support the team in its future successes,” Mr. Villa said.

Jadex Inc. is a US-based manufacturing and material science company utilizing innovation and technology to develop sustainable products that serve the medical, industrial and consumer markets. www.Jadexinc.com